CTRI/2022/09/046002尚未招募未知
An open label, retrospective, observational, non-inferior study to Investigate the Potential of Deep Learning in Assessing the chest diseases Depicted on Digital Chest Radiographs and to Compare Its Performance with Certified Radiologists
MANENTIA ADVISORY PRIVATE LIMITED0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. The dataset consists of many X-rays images.
- •2. Subject dataset specific for the class label.
- •3. X-ray dataset with any of the below pathological conditions.
- •Pneumothorax, Pleural effusion, Pleural thickening, Pneumonia (Lobar and Segmental), Malignancy, Mediastinal pathology, Reticular pattern, Nodular pattern, Fibrocalcific lesion, Emphysema, COPD, Bronchiectasis, Cavity, Pulmonary Oedema, Collapse, Foreign Body, Bone pathologies, Normal condition
排除标准
- •1. Dataset that does not consist of x-ray images
- •2. Incomplete or unreliable data, such as the age, gender, and status at the time of the X-ray recording.
- •3. Dataset and X-ray which do not comply with inclusion criteria
研究者
相似试验
已完成
4 期
Evaluation of efficacy and safety of Itraconazole capsule and Amorolfine cream in skin infectionsCTRI/2019/04/018560Rajiv Gandhi Medical College and Chhatrapati Shivaji Maharaj Hospital
已完成
Unknown
An open, single center, clinical investigation to evaluate the efficacy and safety of woman ISDIN Vaginal Moisturizer on symptomatic vaginal atrophy in post menopausal womaEfficacy and safety of Woman ISDIN® Vaginal Moisturizer in the alleviation of vaginal atrophy symptomsSkin and Connective Tissue DiseasesISRCTN78747508Isdin (Spain)43
已完成
4 期
A study to assess the safety and effectiveness of Indacaterol/ Mometasone DPI in asthma patients.CTRI/2023/05/052297Glenmark Pharmaceuticals Ltd174
已完成
不适用
Observational study to determine effectiveness and safety of Formoterol / Budesonide FDC synchrobreathe inhaler in patients with Chronic Obstructive Pulmonary Disease.CTRI/2021/08/035431Cipla Ltd250
已完成
4 期
A study to assess the control of asthma and ease of use of inhaler device (Synchrobreathe) with the medicine (Seroflo-Salmetrol/Fluticasone FDC) in routine clinical practiceCTRI/2018/12/016629Cipla Ltd490